336 related articles for article (PubMed ID: 28370667)
1. Improving outcomes in veterans with oropharyngeal squamous cell carcinoma through implementation of a multidisciplinary clinic.
Light T; Rassi EE; Maggiore RJ; Holland J; Reed J; Suriano K; Stooksbury M; Tobin N; Gross N; Clayburgh D
Head Neck; 2017 Jun; 39(6):1106-1112. PubMed ID: 28370667
[TBL] [Abstract][Full Text] [Related]
2. Improving access and timeliness of care for veterans with head and neck squamous cell carcinoma: A multidisciplinary team's approach.
Patil RD; Meinzen-Derr JK; Hendricks BL; Patil YJ
Laryngoscope; 2016 Mar; 126(3):627-31. PubMed ID: 26267427
[TBL] [Abstract][Full Text] [Related]
3. ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.
Beitler JJ; Quon H; Jones CU; Salama JK; Busse PM; Cooper JS; Koyfman SA; Ridge JA; Saba NF; Siddiqui F; Smith RV; Worden F; Yao M; Yom SS;
Head Neck; 2016 Sep; 38(9):1299-309. PubMed ID: 27330003
[TBL] [Abstract][Full Text] [Related]
4. Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
Yu Y; Mabray M; Silveira W; Shen PY; Ryan WR; Uzelac A; Yom SS
Head Neck; 2017 Mar; 39(3):432-438. PubMed ID: 27726241
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma.
Lim MY; Dahlstrom KR; Sturgis EM; Li G
Head Neck; 2016 Aug; 38(8):1139-44. PubMed ID: 27002307
[TBL] [Abstract][Full Text] [Related]
6. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
7. Transoral laser microsurgery for oropharyngeal squamous cell carcinoma: A paradigm shift in therapeutic approach.
Wilkie MD; Upile NS; Lau AS; Williams SP; Sheard J; Helliwell TR; Robinson M; Rodrigues J; Beemireddy K; Lewis-Jones H; Hanlon R; Husband D; Shenoy A; Roland NJ; Jackson SR; Bekiroglu F; Tandon S; Lancaster J; Jones TM
Head Neck; 2016 Aug; 38(8):1263-70. PubMed ID: 27042800
[TBL] [Abstract][Full Text] [Related]
8. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary head and neck cancer clinic and adherence with speech pathology.
Starmer H; Sanguineti G; Marur S; Gourin CG
Laryngoscope; 2011 Oct; 121(10):2131-5. PubMed ID: 21826674
[TBL] [Abstract][Full Text] [Related]
10. Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery.
Broglie MA; Stoeckli SJ; Sauter R; Pasche P; Reinhard A; de Leval L; Huber GF; Pezier TF; Soltermann A; Giger R; Arnold A; Dettmer M; Arnoux A; Müller M; Spreitzer S; Lang F; Lutchmaya M; Stauffer E; Espeli V; Martucci F; Bongiovanni M; Foerbs D; Jochum W
Head Neck; 2017 Oct; 39(10):2004-2015. PubMed ID: 28691255
[TBL] [Abstract][Full Text] [Related]
11. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
[TBL] [Abstract][Full Text] [Related]
13. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
Zumsteg ZS; Kim S; David JM; Yoshida EJ; Tighiouart M; Shiao SL; Scher K; Mita A; Sherman EJ; Lee NY; Ho AS
Cancer; 2017 May; 123(9):1555-1565. PubMed ID: 28001302
[TBL] [Abstract][Full Text] [Related]
14. Oropharyngeal squamous cell carcinoma in the veteran population: Association with traditional carcinogen exposure and poor clinical outcomes.
Sandulache VC; Hamblin J; Lai S; Pezzi T; Skinner HD; Khan NA; Dioun SM; Hartman C; Kramer J; Chiao E; Zhou X; Zevallos JP
Head Neck; 2015 Sep; 37(9):1246-53. PubMed ID: 24801106
[TBL] [Abstract][Full Text] [Related]
15. Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck.
Inohara H; Takenaka Y; Yoshii T; Nakahara S; Yamamoto Y; Tomiyama Y; Seo Y; Isohashi F; Suzuki O; Yoshioka Y; Sumida I; Ogawa K
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):934-41. PubMed ID: 25832686
[TBL] [Abstract][Full Text] [Related]
16. Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging.
Rios Velazquez E; Hoebers F; Aerts HJ; Rietbergen MM; Brakenhoff RH; Leemans RC; Speel EJ; Straetmans J; Kremer B; Lambin P
Radiother Oncol; 2014 Dec; 113(3):324-30. PubMed ID: 25443497
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
[TBL] [Abstract][Full Text] [Related]
18. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
[TBL] [Abstract][Full Text] [Related]
19. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
20. NO SToPS: Assessment of a Supportive Care Program to Reduce Treatment Breaks in Patients With Head and Neck Cancer.
Lambertz CK; Tivis R; Hansen K
Clin J Oncol Nurs; 2018 Dec; 22(6):666-668. PubMed ID: 30452009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
